ibmc01 ibmc02 ibmc03 ibmc04 ibmc05 ibmc06 ibmc07 ibmc08 ibmc09 ibmc10 ibmc11 ibmc12
jQuery Image Slider by v2.0
web del Instituto de Biología Molecular y Celular


The IBMC, initially centred on a multidisciplinary approach at the molecular and cellular levels in the fields of biotechnology and health, has in the last two years oriented its activities towards implementing a multidisciplinary, translational program of excellence around the discovery, validation and development of bioactive molecules with biotechnological and therapeutic applications, serving as a channel to bring the interests of academic research in these fields closer to the industrial and service sectors. During the years since its creation, the Institute has reached scientific maturity demonstrated by the number and the quality of its scientific publications in international journals as well as by the volume of economic resources obtained from competitive sources. The Institute also carries out intense activity in translational research and technology transfer which has yielded, for example, more than 29 patents, and the creation of spin-off companies, as well as having helped to maintain an excellent relationship with business and industry. These activities are developed within the institutional agreements reached by the Cooperation Agreement between the UMH and the Regional Government Health Department, to promote scientific cooperation and personnel mobility between the IBMC and the General University Hospital of Elche and its foundation, and to create University-Company Mixed Units, such as that formed with Lipotec Group in the year 2000, in the field of biotechnology, pharmaceutics and chemistry or later with the multinational JBT in the agriculture-food industry.

In scientific terms, the research activity at the IBMC is conducted around two lines of research to be later addressed in further detail here:

From the IBMC two technological platforms have been created: a) the Biological Screening Platform, whose mission is to develop, validate and use biological assays for the screening of synthetic and natural compounds found in chemolibraries with the objective of identifying biologically active compounds; and b) the Skin Research Platform (SRP), a public-private initiative whose mission is to conduct molecular and cellular research in all aspects related to human and animal skin, including physiopathology, therapy and biotechnology.

On the other hand, the Institute's teaching efforts are mainly focused on the PhD Program in Molecular and Cell Biology, given an Award for Excellence by the Spanish Government (Ref. MEE2011-0637) and which has a large number of students.